| 33.10 Data as of May 21 | 0.00 / 0.00%Today’s Change | 25.28 Today|||52-Week Range 36.25 | +19.93% Year-to-Date |
| SECTOR Health Services | INDUSTRY Medical/Nursing Services | MARKET CAP $263.0M |
Company Description
Fresenius Medical Care AG & Co. KGaA is engaged in providing products and services for kidney dialysis patients. It operates through the North America and International segments. Both segments provide dialysis care services and distributes products and equipment for the treatment of end stage renal disease. It also offers chronic hemodialysis, home and acute therapies, therapeutic Apheresis, liver and therapy support, and renal pharmaceuticals. The company was founded in 1975 and is headquartered in Bad Homburg vor der Höhe, Germany.
Employees

Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Rice Powell | Chairman-Management Board & CEO |
| Kent Wanzek | CEO-Global Manufacturing Operations |
| Michael Brosnan | Chief Financial Officer & Member-Management Board |
| Olaf Schermeier, PhD | CEO-Global Research & Development |
| Rainer Runte, PhD | CAO-Global Law, Compliance & Intellectual Property |